Genetic variants in the NF-κB signaling pathway (NFKB1, NFKBIA, NFKBIZ) and risk of critical outcome among COVID-19 patients.
Hum Immunol
; 83(8-9): 613-617, 2022.
Article
in En
| MEDLINE
| ID: mdl-35777990
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
NF-kappa B
/
COVID-19
Type of study:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Hum Immunol
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: